Lung Foundation Australia is proud to share the ALCC 2023 Scientific Committee. The Scientific Committee will help to design and shape your ALCC 2023 Program.
Prof Fraser Brims
Scientific Program Chair
The Australian Lung Cancer Conference 2023 (ALCC 2023) is excited to announce that Professor Fraser Brims has been elected as Chair of the Scientific Committee for the Conference.
Professor Fraser Brims is a Consultant Respiratory Physician at Sir Charles Gairdner Hospital and Director of Clinical Skills at Curtin University Medical School. He is the Deputy Director of the Institute of Respiratory Health and Chairs the Western Australian Mesothelioma Registry. His main research interests include clinical and epidemiological aspects of occupational (particularly asbestos) related lung disease, mesothelioma and detection of early lung cancer using low dose CT scans.@underwaterdoc
Mr Stephen Barnett
Lung & Sleep Victoria
Mr Barnett completed his Bachelor of Medicine and Bachelor of Surgery at the University of Melbourne in 1996 and has trained in general surgery, having received a Fellowship from the Royal Australasian College of Surgeons in General Surgery in 2004. He is a qualified Cardiothoracic Surgeon having received his Fellowship in Cardiothoracic Surgery from the Royal Australasian College of Surgeons in 2009. He undertook a Fellowship in 2008 at the Memorial Sloan Kettering Cancer Centre, U.S.A. as the Thoracic Surgical Oncology International Fellowship and a Fellowship in 2009 at the Brigham & Women’s Hospital, Harvard University, Boston, U.S.A. as an international Cardiac Surgical Fellow.
He is currently appointed as a Senior Lecturer in the Department of Surgery of the University of Melbourne and as a Consultant Thoracic Surgeon at the Austin Hospital, Sir Peter McCallum Cancer Centre, Royal Melbourne and Western General Hospitals. He is part of the Multi-Disciplinary team at all four centres caring for patients with thoracic malignancy.
Dr Vanessa Brunell
Queensland University Technology
Dr Vanessa Brunelli is a Research Fellow appointed by Queensland University of Technology. Vanessa’s program of research centres on understanding the role and capabilities of the specialist lung cancer nurse. Her postdoctoral research includes a national study investigating the core supportive care components of the specialist lung cancer nurse role that appear most influential to patient experience, to inform Australia’s first discrete specialist lung cancer nurse workforce model. This study is supported by an inaugural Lung Foundation Australia Shine a Light on Lung Cancer Early Career Research Fellowship. To date, Vanessa has attracted over $500,000.00 in competitive grant funding (including an NHMRC PhD scholarship) to undertake research into the role and capabilities of the specialist lung cancer nurse.
Vanessa also maintains a strong commitment to professional leadership in the field of lung cancer research and education, and capacity building in the lung cancer nursing workforce. Vanessa is the Chair of the Steering Committee, Australia and New Zealand Lung Cancer Nurses Forum (ANZ-LCNF), Lead of the ANZ-LCNF Research and Education portfolios, and Australian Representative on the Steering Committee, International Thoracic Oncology Nurses Forum. Vanessa is an Invited Member on the Scientific Committee, Thoracic Oncology Group of Australasia, Invited Member on the Expert Advisory Committee, Lung Cancer Blueprint 2.0, Lung Foundation Australia, Invited Member on the Expert Advisory Committee, Lung Cancer Consultative Group, Lung Foundation Australia, and a Visiting Scholar of the International Centre for Community Driven Research, Geneva
Dr Tracy Leong
Dr Tracy Leong is a clinician-scientist with dual appointments as a Respiratory physician and Director of Interventional Pulmonology at Austin Health (Victoria) and as a lung cancer post-doctorate at the Walter and Eliza Hall Institute for Medical Research (Victoria). Her specific interests are in lung cancer biobanking for translational research and in profiling immunotherapy resistance. She is also President of TSANZ VIC and TSANZ Board lung cancer lead, through which she works closely with Lung Foundation Australia and Thoracic Oncology Group of Australasia.
A/Prof Henry Marshall
A/Prof Henry Marshall, FRACP PhD, is a senior staff Thoracic Physician at The Prince Charles Hospital, Brisbane and Visiting Medical Officer at St Vincent’s Private Hospital Northside, Brisbane. His research, at the University of Queensland Thoracic Research Centre, aims to reduce the burden of disease caused by lung cancer by focussing on lung cancer early detection, screening and smoking cessation. He is an investigator on both of Australia’s lung cancer screening trials, the International Lung Screen Trial, and the pilot forerunner, the Queensland Lung Cancer Screening Study. He holds an NHMRC Investigator Grant to develop a smoking cessation chatbot powered by artificial intelligence, and a Queensland Health Research Fellowship and a Metro North HHS Research Fellowship for his work in lung cancer screening.
A/Prof Nicole Rankin
The University of Melbourne
Associate Professor Nicole Rankin is an implementation scientist currently from at the University of Sydney where she is Director of the Implementation Science Program at Sydney Health Partners.
Nicole completed a PhD in Behavioural Science in Relation to Medicine at the University of Newcastle in 2000 and has experience working across government cancer agencies (National Breast Cancer Centre, 2001-2003, Cancer Institute NSW, 2004-2006), cancer charities (Cancer Council NSW 2017-2019) and academia (2006-2009; 2012-ongoing). She was awarded an International fellowship in the Mentored Training in Dissemination and Implementation Research in Cancer (MT-DIRC), Washington University in St Louis, USA (2016-2018) and in 2020 was the recipient of the Lesley J. Fleming Churchill Fellowship (Health and Medicine category).
A major focus of Nicole's research interests is lung cancer; her research portfolio in this context extends from screening, early detection, and management through multidisciplinary care through to palliation and survivorship
A/Prof Rob Stirling
Victorian Lung Cancer Registry
Associate Professor Robert Stirling is a Senior Respiratory Specialist and Lead Clinician at Alfred Lung Cancer Multidisciplinary Meeting at The Alfred Hospital, Prahran as well as treating medical specialist at Epworth Health, Richmond.
Robert is currently an honorary lecturer and senior clinical educator at Monash University, Department of Medicine and is actively involved in clinical teaching with third and final year Monash University medical students, resident medical officers and respiratory registrars.
His sub-specialist interests are allergy immunology including asthma, rhinitis, urticaria, bronchiectasis, COPD, inflammatory lung disease and lung cancer. His research interests include the improvement of quality of care in lung cancer, and chronic sinus and lung infection and the multidisciplinary meetings in lung cancer care. Robert is the co-coordinating principle investigator for the VLCR, and chair of the VLCR Steering Committee. He has recently completed and published an expert panel consensus guidelines for the International Consortium for Health Outcomes Measurement for Lung Cancer and has over 60 peer reviewed publications and conference abstract publications in the area of respiratory medicine.
Dr Sukhwiner Singh Sohal
University of Tasmania
Dr Sukhwiner Singh Sohal is Head of the Respiratory Translational Research Group and Senior Lecturer in Laboratory Medicine at School of Health Sciences, University of Tasmania (UTAS), Launceston. He graduated from his PhD in Respiratory Immunopathology from UTAS in 2010. In addition, he has a Masters in Biochemical Pharmacology, a Masters in Molecular Biology and Biochemistry and a Bachelor of Science from universities in the UK and India.
His research group investigates cellular and molecular mechanisms underlying chronic lung diseases such as COPD, lung cancer, Asthma COPD Overlap Syndrome (ACOS), asthma, pulmonary hypertension, idiopathic pulmonary fibrosis and lymphangioleiomyomatosis (LAM). He is Director of the Tasmanian Lung Cancer Registry. His lab is also home to investigations looking at effects of electronic smoking devices on lung health such as e-cigarettes and heat-not-burn devices.
Dr Sohal is the Board Director for the Thoracic Society of Australia and New Zealand (TSANZ), Australia’s peak body for respiratory and sleep medicine and President TSANZ Tasmania Branch. In addition, he has served in different roles such as convenor for the COPD SIG, member of the TSANZ Education and Training Sub-Committee and Research Sub-Committee. He also serves on the Medical and Scientific Advisory Panel of LAM Australia Research Alliance. Dr Sohal serves on the European Board for Accreditation in Pneumology. In 2016, for his contributions to chronic lung disease, he was elected Fellow of the Asian Pacific Society of Respirology (FAPSR).@Romy_Sohal
Ashleigh Sharman is a PhD candidate investigating optimising participation in a potential lung cancer screening program by high-risk individuals in the Australian setting. Her research interests include the use of implementation science methodologies within cancer screening and cancer prevention research. Ashleigh is also a research assistant within academic and clinical trial settings. With more than 15 years communications experience in public relations, marketing and publishing, Ashleigh is an accomplished freelance copywriter and editor.
A/Prof Emily Stone
Emily Stone is a respiratory physician and clinical researcher at St Vincent’s Hospital Sydney and School of Clinical Medicine UNSW. Her specific research interests include quality use of clinical data, lung cancer screening and tobacco control. She is Deputy Chair of the Thoracic Oncology Group of Australasia, Convenor of the TSANZ Tobacco Control SIG and immediate past Head of the Lung Cancer Assembly of the Asia Pacific Society of Respirology.
A/Prof Kate Sutherland
Laboratory Head, Cancer Biology and Stem Cells Division
The Walter and Eliza Hall Institute of Medical Research
A/Prof Kate Sutherland is a Laboratory Head at The Walter and Eliza Hall Institute of Medical Research (WEHI). Her translational research program is dedicated to understanding tumour heterogeneity in lung cancer. Her work has established new approaches and technologies to study lung cancer, leading to seminal findings on the cell-of-origin, genetic drivers, the immune microenvironment, and the role of the metabolome in lung cancer. Kate has been the recipient of funding from Worldwide Cancer Research (UK), NHMRC and the Victorian Cancer Agency and currently leads a national NHRMC Synergy Grant focused on identifying resistance mechanisms to KRAS inhibitor therapies. Kate passionately advocates for women in science, educating the next generation of research scientists and the value of fundamental lung cancer research in improving the treatment of patients.@Sutherland_Lab
Lung Cancer Advocate
Lorraine was diagnosed first with Breast Cancer and then with Lung Cancer in 2017. She quickly realized that the response to a Lung Cancer diagnosis is completely lacking compared to the response to a Breast Cancer diagnosis. Also, it became apparent that the outcomes for Lung Cancer patients in general, and for her specifically, are considerably worse than for Breast Cancer patients.
As a result, Lorraine has been passionately advocating for better care and outcomes for Lung Cancer patients since 2018. She has taken her message to Federal politicians both in government and in opposition. She has also successfully advocated within her own state about the lack of Lung Cancer Nurses there.
Finding no peer support locally Lorraine started an informal Lung Cancer Support Group in SA – the Lovely Lungs. She is working with a researcher in SA looking at tailoring the dose of targeted therapy given to Lung Cancer patients.
Lorraine does not hesitate to take her message to the media including journalists, ABC TV, ABC radio, on-line news services. She is chair of the Lung Foundation Australia’s Lung Cancer Patient Advisory Group and sits on several committees working to shape a better future for lung cancer patients.
Dr Lara Edbrooke
Physiotherapy Department at the University of Melbourne
Allied Health Research Development lead at the Peter MacCallum Cancer Centre
Dr Lara Edbrooke is a physiotherapist with more than 20 years rehabilitation experience. Lara is a senior lecturer within the Physiotherapy Department at the University of Melbourne and the Allied Health Research Development lead at the Peter MacCallum Cancer Centre. She completed her PhD in 2019 investigating the effects of a home-based multi-disciplinary rehabilitation program for people with inoperable lung cancer. With a 2020 Cancer Council Victoria fellowship she undertook a cost-effectiveness analysis of this intervention. Lara is a current Victorian Cancer Agency early career research fellow. Her key interests focus on improving outcomes for people with cancer through the development of novel models of multi-disciplinary care, technology use and the measurement of physical activity.
Prof Kwun Fong
Professor with the University of Queensland School of Medicine
Thoracic and Sleep Physician at The Prince Charles Hospital
Professor Kwun Fong is a Thoracic and Sleep Physician at The Prince Charles Hospital and Professor with the University of Queensland School of Medicine. He is Clinical Manager of the Pulmonary Malignancy Unit at TPCH and Director of the UQ Thoracic Research Centre which undertakes molecular, genomic and translational research in lung diseases. He is privileged to serve as Chair of Lung Foundation Australia’s Lung Cancer Clinical Advisory Committee, Co-Editor of the Cochrane Lung Cancer Review Group and is a Deputy Editor for the Journal of Thoracic Diseases.
- Call for Abstracts
- Opens 1 June 2022
- Closes 31 August 2022
- Notifications sent Mid-September 2022
- Early Bird Registration
- Early Bird closes 15 October 2022
- Australian Lung Cancer Conference 2023
- Conference dates 15 - 17 February 2023